K911171 is an FDA 510(k) clearance for the ACS THERAPEUTIC DRUG MONIT CONTR, SET II LEVEL III. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.
Submitted by Analytical Control Systems, Inc. (Fishers, US). The FDA issued a Cleared decision on May 1, 1991 after a review of 47 days - a notably fast clearance cycle.
This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.1660 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Analytical Control Systems, Inc. devices